USFDA Advisory Committee reviews Roche Columvi Combo for diffuse large B-cell Lymphoma Ruchika Sharma21 May 2025 1:45 PM ISTBasel: Roche has announced that a US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) discussed the supplemental...
NK cells complexed with bispecific antibody yield high response rates in patients with lymphoma: Study Dr. Kamal Kant Kohli23 April 2025 8:30 PM ISTA novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific...
Roche Columvi gets European Commission nod as bispecific antibody for diffuse large B-cell lymphoma after initial therapy Ruchika Sharma14 April 2025 12:30 PM ISTBasel: Roche has announced that the company has received approval from the European Commission for Columvi (glofitamab) in...
Tattoos may be linked to increased risk of cancer, reveals research Dr. Kamal Kant Kohli6 March 2025 8:45 PM ISTPeople often put a lot of thought into getting a tattoo. But there's one thing most people forget to think about-what impact the tattoo might have on...
Safdarjung Hospital successfully conducts pediatric bone marrow transplant Dr. Garima Soni13 Sept 2024 9:00 AM ISTThe Centre-run Safdarjung Hospital has achieved a significant milestone by successfully conducting its first pediatric bone marrow transplant on a...
Health Bulletin 12/ September/ 2024 Dr. Garima Soni12 Sept 2024 5:34 PM ISTHere are top health stories for the day:Safdarjung Hospital doctors conduct first successful paediatric bone marrow transplantThe Centre-run...
Doctors at Safdarjung Hospital conducts first successful paediatric bone marrow transplant Kajal Rajput12 Sept 2024 9:30 AM ISTNew Delhi: The Centre-run Safdarjung Hospital has achieved a significant milestone by successfully conducting its first pediatric bone marrow...
People with tattoos at higher risk of developing lymphoma, claims study Roshni Dhar31 May 2024 3:28 PM ISTNowadays, tattoos have become a popular form of self-expression, with many individuals sporting one or more designs on their skin. However, a new...
Health Bulletin 30/ May/ 2024 Roshni Dhar30 May 2024 5:15 PM ISTHere are the top health news for the day:Pune hospital's action against doctors who 'switched' teen driver's blood sampleIn the latest twist in the...
Recalculate sample size based on serious adverse event: CDSCO Panel Tells Roche on Polatuzumab vedotin study Dr. Divya Colin25 March 2024 6:00 PM ISTNew Delhi: In line with the Phase IV clinical trial protocol of Polatuzumab Vedotin for Injection, 30mg/vial and 140 mg/vial, the Subject Expert...
Cancer Care: Over 600,000 International patients travel to India every year Kajal Rajput18 Feb 2024 11:15 AM ISTNew Delhi: Patient Herbert from Tanzania, suffering from non-Hodgkin lymphoma (A type of blood cancer), came to India for treatment last year. Now,...
Liso-cel cost effective second-line treatment for common form of lymphoma Dr. Kamal Kant Kohli2 Jan 2024 6:00 AM ISTLisocabtagene maraleucel (liso-cel), a CAR T-cell therapy, is a cost effective second line treatment for relapsed and refractory (hard to treat)...
